[由甲状腺功能障碍引起的肝脏内胆固醇和高 bilirubinemia:一个案例系列]
Juan Pablo Sánchez Garcés1, María Clara Ospino Guerra2, Jarny José Morales Marenco3
1Residente Especialización en Medicina Interna, Grupo de Investigación CIFACS, Universidad Libre Seccional Barranquilla, Colombia. Especialista Gerencia de la Salud, Fundación Universitaria de Ciencias de la Salud, Colombia. Barranquilla, Colombia. Universidad Libre Grupo de Investigación CIFACS Universidad Libre Barranquilla Colombia.
甲状腺功能障碍会导致肝脏问题,包括严重的黄 (高胆血症). 这一案例系列突出了罕见的情况,甲状腺激素过量导致显著的直接高 bilirubinemia 和胆固醇.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
背景情况:
- 甲状腺功能障碍,甲状腺激素的过度产生的情况,经常影响肝功能.
- 常见的肝脏生化变化包括性酸酶,氨基转移酶的升高,以及轻度的高白血症.
- 严重的高胆血是甲状腺功能障碍症的一个不常见的表现.
研究的目的:
- 报告两例罕见的严重直接大胆血病病例.
- 为了研究甲状腺功能障碍症和严重的直接超白血症之间的关联,包括肝脏内胆固醇症.
主要方法:
- 案例报告分析.情况报告分析.
- 对临床表现,实验室发现和生物化学数据的审查.
- 评估肝功能测试和甲状腺激素水平.
主要成果:
- 两名患者呈现出严重的直接超白血症.
- 一名患者也表现出肝脏内胆固醇形成的迹象.
- 这两种病例都与潜在的甲状腺功能障碍有关.
结论:
- 严重的直接高 bilirubinemia 和肝脏内胆固醇衰竭是罕见的,但公认的甲状腺功能障碍的表现.
- 在患有这些肝脏异常的患者中,高甲状腺症的及时诊断和管理至关重要.
更多相关视频
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
11:36Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
相关概念视频
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
